Skip to main content
MASIMO CORP logo

MASIMO CORP — Investor Relations & Filings

Ticker · MASI ISIN · US5747951003 LEI · 549300Q4A8JK0PIYCU29 US Manufacturing
Open in API
Filings indexed 1,253 across all filing types
Latest filing 2017-10-31 Interim / Quarterly Rep…
Country US United States of America
Listing US MASI

About MASIMO CORP

https://www.masimo.com/

Masimo is a global medical technology company that develops, manufactures, and markets a wide array of noninvasive patient monitoring technologies. The company's core offering is its proprietary Signal Extraction Technology (SET®) pulse oximetry, renowned for its ability to provide accurate measurements during patient motion and low peripheral perfusion. Masimo's product portfolio also includes advanced solutions for brain function monitoring (SedLine®), regional oximetry (O3®), and integrated patient monitoring and connectivity platforms like Root®. These technologies are designed to improve patient outcomes, enhance patient safety, and streamline clinical workflows in various healthcare settings, including hospitals, emergency medical services, and home care. The company focuses on creating innovative solutions that empower clinicians with reliable data to make critical care decisions.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q3 2017
2017-10-31 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated October 31, 2017, for Masimo Corporation. It announces the issuance of a press release reporting the financial results for the quarter ended September 30, 2017. The document itself does not contain detailed financial statements or substantive financial data but references the press release as an exhibit. The length is under 5,000 characters and the document primarily serves as an announcement of the earnings release rather than the earnings release itself. According to the classification rules, such a document is best classified as an Earnings Release (ER) since it announces quarterly financial results, but since it is a Form 8-K referencing a press release, it aligns with the Earnings Release category rather than a full quarterly report or other filings.
2017-10-31 English
FORM 4
Director's Dealing
2017-10-17 English
FORM 3
Director's Dealing
2017-10-17 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated September 22, 2017, reporting the appointment of a new Executive Vice President and Chief Financial Officer, Micah Young. It details his background, compensation, and terms of employment. The key section is Item 5.02, which relates to the departure and appointment of directors or certain officers. There is no financial data or report attached; the document is an announcement of management changes. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is 6812 characters, which is sufficient for a detailed announcement rather than a brief notice. Therefore, the correct classification is MANG with high confidence.
2017-09-25 English
FORM 4
Director's Dealing
2017-08-26 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.